In his Diffusion article from the July/August issue of The Hematologist, Dr. Adam Cuker (University of Pennsylvania) covers options to reduce the incidence of heparin-induced thrombocytopenia (HIT), treating it as a preventable nosocomial disease rather than an unavoidable iatrogenic disorder. He looks at the study “Reducing the hospital burden of heparin-induced thrombocytopenia: impact of an avoid-heparin program,” which was led by Dr. William Geerts (Sunnybrook Health Sciences Center) who joins Dr. Cuker in this stimulating conversation. You can find Dr. Cuker’s Diffusion article online at www.hematology.org/Thehematologist/Diffusion/5646.aspx.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/